Drug shortages during the study period may have caused some temporary discontinuations that looked like intentional stops
From an application perspective, the report encompasses major therapeutic areas including type 2 diabetes management, representing nearly 58% of usage, obesity treatment at around 32%, and cardiovascular and metabolic disorders accounting for approximately 10%
Supports long-term weight control-not just quick fixes
Decreasing Glucagon Secretion: It reduces the release of glucagon, another hormone that raises blood sugar, further contributing to glycemic control
Ideal for discoloration and skin aging
Cohen S, Kamarck T, Mermelstein R